Research Faculty

Ya-Wei Qiang, M.D., Ph.D.
Assistant Professor of Medicine

Ph.D., Department of Molecular and Tumor Pathology, Chiba University School of Medicine, Japan
M.S., Department of Hematology/Oncology, Xian Medical University, China
M.D., Xian Medical University, China
Postdoctoral fellowship, Laboratory of Cellular and Molecular Biology, National Cancer Institute, NIH, Bethesda, Maryland

Selected Publications:

1. Qiang YW, Walsh K, Yao L, Kedei N, Blumberg P, Rubin J, Shaughnessy J Jr. and Rudikoff S. Wnts induce migration and invasion of myeloma cells via activation of RhoA and PKC pathways. Blood. 2005; 106(5): 1786-93
2.  Qiang YW and Stuart Rudikoff. Wnt signaling in B and T lymphocytes.  Front  Biosci. 2004; 9: 1000-10
3. Qiang YW, Yao L, Tosato G, Rudikoff S. Insulin-like Growth Factor I induces migration and invasion of human multiple myeloma cells. Blood. 2004; 103(1): 301-8.
4. Qiang YW, Endo Y, Rubin J, Rudikoff S. Wnt Signaling in B cell Neoplasia. Oncogene. 2003; 22(10): 1536-45.
5. Qiang YW, Kopantzev E, Rudikoff S. Insulin-like growth factor-I signaling in multiple myeloma: downstream elements, functional correlates and pathway cross talk. Blood.2002; 99(11): 4138-46.
6.  Qiang YW, Kitagawa M,  Morihiro H, Ishii G, Morimoto C, Harigaya K. Activation of mitogen-activated protein kinase through a5b integrin are required for the cell cycle progression of B progenitor cell line, Reh, on stromal cells. Exp Hematol. 2000; 28(10): 1147-57

Having problems with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
Terms and Conditions of Use

The information on the Myeloma Institute web site is not intended as a substitute for professional medical attention. The information is intended only as an aid in understanding current medical knowledge. A physician should always be consulted for any health concern or medical condition. The Myeloma Institute web site provides links to other organizations as a service to our readers. The Myeloma Institute is not responsible for the information provided on other web sites.